These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1394043)

  • 1. Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer.
    Olt G; Berchuck A; Soisson AP; Boyer CM; Bast RC
    Cancer; 1992 Oct; 70(8):2137-42. PubMed ID: 1394043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.
    Elg SA; Mayer AR; Carson LF; Twiggs LB; Hill RB; Ramakrishnan S
    Cancer; 1997 Oct; 80(8):1448-56. PubMed ID: 9338469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA; Hill RB; Heldman L; Ramakrishnan S
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
    Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
    Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of peptide growth factors in epithelial ovarian cancer.
    Berchuck A; Olt GJ; Everitt L; Soisson AP; Bast RC; Boyer CM
    Obstet Gynecol; 1990 Feb; 75(2):255-62. PubMed ID: 2300354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer ascites-derived vitronectin and fibronectin: combined purification, molecular features and effects on cell response.
    Carduner L; Agniel R; Kellouche S; Picot CR; Blanc-Fournier C; Leroy-Dudal J; Carreiras F
    Biochim Biophys Acta; 2013 Oct; 1830(10):4885-97. PubMed ID: 23811340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma.
    Wilhelm O; Hafter R; Coppenrath E; Pflanz MA; Schmitt M; Babic R; Linke R; Gössner W; Graeff H
    Cancer Res; 1988 Jun; 48(12):3507-14. PubMed ID: 3130986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.
    Miyamoto S; Ruhaak LR; Stroble C; Salemi MR; Phinney B; Lebrilla CB; Leiserowitz GS
    J Proteome Res; 2016 Sep; 15(9):3358-76. PubMed ID: 27500424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.
    Shibata K; Kikkawa F; Nawa A; Suganuma N; Hamaguchi M
    Cancer Res; 1997 Dec; 57(23):5416-20. PubMed ID: 9393769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells.
    Tiper IV; Temkin SM; Spiegel S; Goldblum SE; Giuntoli RL; Oelke M; Schneck JP; Webb TJ
    Clin Cancer Res; 2016 Aug; 22(16):4249-58. PubMed ID: 27076627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
    Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
    Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the immunophenotype of ovarian cancer cells by N,N-dimethylformamide and transforming growth factor-beta 1.
    Grunt TW; Oeller H; Somay C; Dittrich E; Fazeny B; Mannhalter C; Dittrich C
    J Cell Physiol; 1993 Aug; 156(2):358-66. PubMed ID: 8344991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
    Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
    Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin promotes epithelial migration of cultured rabbit cornea in situ.
    Nishida T; Nakagawa S; Awata T; Ohashi Y; Watanabe K; Manabe R
    J Cell Biol; 1983 Nov; 97(5 Pt 1):1653-7. PubMed ID: 6415071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.
    Jeschke U; Mylonas I; Kunert-Keil C; Stahn R; Scholz C; Janni W; Kuhn C; Schröder E; Mayr D; Friese K
    Histochem Cell Biol; 2009 Feb; 131(2):283-95. PubMed ID: 18853174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the fibronectin synthesized by human germ cell tumors.
    McIlhinney RA; Patel S
    Cancer Res; 1983 Mar; 43(3):1282-8. PubMed ID: 6825099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive factors in ascites fluids from ovarian cancer patients.
    Fumita Y; Tanaka F; Saji F; Nakamuro K
    Am J Reprod Immunol (1980); 1984 Dec; 6(4):175-8. PubMed ID: 6528882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice.
    Voutsas IF; Pistamaltzian N; Tsiatas ML; Skopeliti M; Katsila T; Mavrothalassiti I; Spyrou S; Dimopoulos MA; Tsitsilonis OE; Bamias A
    Eur J Cancer; 2013 May; 49(7):1706-14. PubMed ID: 23276721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid.
    Oh SK; Moolten FL
    Eur J Immunol; 1981 Oct; 11(10):780-8. PubMed ID: 6273181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchial epithelial cells produce lung fibroblast chemotactic factor: fibronectin.
    Shoji S; Rickard KA; Ertl RF; Robbins RA; Linder J; Rennard SI
    Am J Respir Cell Mol Biol; 1989 Jul; 1(1):13-20. PubMed ID: 2624756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.